{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":1,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":21,"n_cols":5,"rows_kept":21,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[3,2,3,3],[4,2,4,3],[5,2,5,3],[6,2,6,3],[9,2,9,3],[10,2,10,3],[14,2,14,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNINA9910452182703321"]
[null,null,"Titolo",null,"Angiotensin converting enzyme inhibitors [[electronic resource] /] / Anne N. DeBrue, editor"]
[null,null,"Pubbl/distr/stampa",null,"New York, : Nova Biomedical Books, c2009"]
[null,null,"ISBN",null,"1-60741-095-8"]
[null,null,"Descrizione fisica",null,"1 online resource (252 p.)"]
[null,null,"Disciplina",null,"572/.744"]
[null,null,"Soggetti",null,"Angiotensin converting enzyme - Inhibitors"]
[{"$nulls":4},"Kidneys - Diseases - Chemotherapy"]
[{"$nulls":4},"Electronic books."]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","Description based upon print version of record."]
[null,null,null,"Nota di bibliografia","Includes bibliographical references and index."]
[null,null,"Nota di contenuto",null,"\"\"ANGIOTENSIN CONVERTING ENZYME INHIBITORS \"\"; \"\"Contents \"\"; \"\"Preface \"\"; \"\"Angiotensin Converting Enzyme Inhibitors \"\"; \"\"Abstract \"\"; \"\"Introduction â€? The Components of the Renin Angiotensin Aldosterone System (RAAS)\"\"; \"\"Structure and Structure Activity Relationships of the ACEIs \"\"; \"\"Clinical Indications and Uses of the ACEIs \"\"; \"\"Adverse Effects of the ACE Inhibitors with Special Reference to Worsening Renal Failure in CKD Patients \"\"; \"\"Conclusion/Post-Script \"\"; \"\"References \"\"; \"\"Adverse Effects of Angiotensin-Converting Enzyme Inhibitor:  A Review of the Literature \"\""]
[{"$nulls":4},"\"\"Abstract  \"\"\"\"Introduction  \"\"; \"\"ACEI-Associated Cough \"\"; \"\" Hypersensitivity Reaction During Hemodialysis \"\"; \"\"ACEI-Associated Anemia \"\"; \"\"ACEI-Induced Lung Disease \"\"; \"\"References \"\"; \"\"Plant-Derived Substances as ACE Inhibitors â€? Biosynthesis-Activity Relationship of Flavonoids, Terpenes and Sterols on Angiotensin-Converting Enzyme Activity in Human  Endothelial Cells \"\"; \"\"Abstract \"\"; \"\"Introduction \"\"; \"\"Aim of this Study \"\"; \"\"Material and Methods \"\"; \"\"Results (Table 1) \"\"; \"\"Conclusion \"\"; \"\"Acknowledgments \"\"; \"\"References \"\""]
[{"$nulls":4},"\"\"The Proper Use of Angiotensin-Converting Enzyme Inhibitors in Patients with Chronic Kidney Disease  \"\"\"\"Abstract\"\"; \"\"Introduction \"\"; \"\"Effects of ACE inhibitors on Renal and Glomerular Hemodynamics \"\"; \"\"Effects of ACE Inhibitors on Proteinuria \"\"; \"\"Increasing the Doses of ACE Inhibitors or the Addition of ARB? \"\"; \"\"Excretion and Plasma Concentration of ACE Inhibitors in Patients with Chronic Renal Failure \"\"; \"\"Upper Limit of Serum Creatinine to Add on ACE Inhibitor \"\"; \"\"Long-"]
[{"$nulls":4},"Term Renoprotective Effects and Escape Phenomenon by Use of ACE Inhibitors \"\""]
[{"$nulls":4},"\"\"Side Effects of ACE Inhibitors in Patients with Chronic Renal Failure \"\"\"\"Influence of Gene Polymorphisms on Renoprotective Effects of ACE Inhibitors \"\"; \"\"Compliance of Taking ACE Inhibitors \"\"; \"\"Additional Therapy with ACE Inhibitors \"\"; \"\"Clinical Approach for Proper Use of ACE Inhibitors \"\"; \"\"Summary  \"\"; \"\"Patients and Methods \"\"; \"\"Acknowledgements \"\"; \"\"References \"\"; \"\"Angiotensin-Converting Enzyme Inhibitors in Coronary Artery Disease and Preserved Left Ventricular  Systolic Function  \"\"; \"\"Abstract \"\"; \"\"Abbreviation: \"\"; \"\"* Median follow-up \"\""]
[{"$nulls":4},"\"\"Potential Mechanisms of ACEI Beneficial Activity in Patients with CAD \"\"\"\"Clinical Uses of ACEI in Cardiovascular Diseases \"\"; \"\"Randomized Clinical Trials Examining the Use of ACEI in Patients with CAD and Preserved LV Systolic Function \"\"; \"\"Ischemia Management with Accupril Post Bypass Graft via Inhibition of Angiotensin Converting Enzyme (IMAGINE) Trial \"\"; \"\"Meta Analysis of the Effects of ACEI in Patients with Normal LV Function and CAD \"\"; \"\"Putting it Together \"\"; \"\"References \"\""]
[{"$nulls":4},"\"\"Dual Blockade of the Renin-Angiotensin System: Angiotensin Converting Enzyme Inhibition, Angiotensin Receptor Blockade and Renin Inhibition\"\""]